(Press-News.org) Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of UCLA researchers have now demonstrated that these cells can actually attack HIV-infected cells in a living organism.
The study, published April 12 in the journal PLoS Pathogens, demonstrates for the first time that engineering stem cells to form immune cells that target HIV is effective in suppressing the virus in living tissues in an animal model, said lead investigator Scott G. Kitchen, an assistant professor of medicine in the division of hematology and oncology at the David Geffen School of Medicine at UCLA and a member of the UCLA AIDS Institute.
"We believe that this study lays the groundwork for the potential use of this type of an approach in combating HIV infection in infected individuals, in hopes of eradicating the virus from the body," he said.
In the previous research, the scientists took CD8 cytotoxic T lymphocytes — the "killer" T cells that help fight infection — from an HIV-infected individual and identified the molecule known as the T cell receptor, which guides the T cell in recognizing and killing HIV-infected cells. However, these T cells, while able to destroy HIV-infected cells, do not exist in great enough quantities to clear the virus from the body. So the researchers cloned the receptor and used this to genetically engineer human blood stem cells. They then placed the engineered stem cells into human thymus tissue that had been implanted in mice, allowing them to study the reaction in a living organism.
The engineered stem cells developed into a large population of mature, multi-functional HIV-specific CD8 cells that could specifically target cells containing HIV proteins. The researchers also discovered that HIV-specific T cell receptors have to be matched to an individual in much the same way an organ is matched to a transplant patient.
In this current study, the researchers similarly engineered human blood stem cells and found that they can form mature T cells that can attack HIV in tissues where the virus resides and replicates. They did so by using a surrogate model, the humanized mouse, in which HIV infection closely resembles the disease and its progression in humans.
In a series of tests on the mice's peripheral blood, plasma and organs conducted two weeks and six weeks after introducing the engineered cells, the researchers found that the number of CD4 "helper" T cells — which become depleted as a result of HIV infection — increased, while levels of HIV in the blood decreased. CD4 cells are white blood cells that are an important component of the immune system, helping to fight off infections. These results indicated that the engineered cells were capable of developing and migrating to the organs to fight infection there.
The researchers did note a potential weakness with the study: Human immune cells reconstituted at a lower level in the humanized mice than they would in humans, and as a result, the mice's immune systems were mostly, though not completely, reconstructed. Because of this, HIV may be slower to mutate in the mice than in human hosts. So the use of multiple, engineered T cell receptors may be one way to adjust for the higher potential for HIV mutation in humans.
"We believe that this is the first step in developing a more aggressive approach in correcting the defects in the human T cell responses that allow HIV to persist in infected people," Kitchen said.
The researchers will now begin making T cell receptors that target different parts of HIV and that could be used in more genetically matched individuals, he said.
INFORMATION:
Other study authors are Bernard R. Levin, Gregory Bristol, Valerie Rezek, Sohn Kim, Christian Aguilera-Sandoval, Arumugam Balamurugan, Otto O. Yang and Jerome A. Zack, all of UCLA.
The National Institutes of Health, the California HIV/AIDS Research Program, the California Institute for Regenerative Medicine, the UC Multicampus Research Program and Initiatives from the California Center for Antiviral Drug Discovery, and the UCLA Center for AIDS Research (CFAR) funded this study.
The UCLA AIDS Institute, established in 1992, is a multidisciplinary think tank drawing on the skills of top-flight researchers in the worldwide fight against HIV and AIDS, the first cases of which were reported in 1981 by UCLA physicians. Institute members include researchers in virology and immunology, genetics, cancer, neurology, ophthalmology, epidemiology, social sciences, public health, nursing and disease prevention. Their findings have led to advances in treating HIV, as well as other diseases, such as hepatitis B and C, influenza and cancer.
For more news, visit the UCLA Newsroom and follow us on Twitter.
END
Imagine a world where the rooftops and pavements of every urban area are resurfaced to increase the reflection of the Sun's light rays. Well, this is exactly what a group of Canadian researchers have done in an attempt to measure the potential effects against global warming.
In a study published today, 13 April, in IOP Publishing's journal Environmental Research Letters, researchers from Concordia University created this scenario to see what effect a global increase in surface reflectance would have on global temperature and our own carbon dioxide (CO2) emissions.
They ...
The UK health insurance brand Health-on-Line offers a fresh approach to medical insurance - with low cost, simple to understand policies that customers can easily tailor to their needs with a selection of add-ons that boost cover where needed.
Bournemouth based Health-on-Line -which was recently acquired by AXA PPP healthcare - provides affordable private medical insurance for individuals, with a special Business Priority Health package for enterprise customers - from sole traders right up to large group schemes.
Health-on-Line have taken a fresh look at medical cover, ...
Researchers at the University of California, Davis have discovered a key tool that helps sperm and eggs develop exactly 23 chromosomes each. The work, which could lead to insights into fertility, spontaneous miscarriages, cancer and developmental disorders, is published April 13 in the journal Cell.
Healthy humans have 46 chromosomes, 23 from the sperm and 23 from the egg. An embryo with the wrong number of chromosomes is usually miscarried, or develops disorders such as Down's syndrome, which is caused by an extra copy of chromosome 21.
During meiosis, the cell division ...
Who will win the big prize? Fans of the new reality series "Fashion Star" on NBC can hardly wait to find out. This unique design show offers merchandizing contracts to each week's winners, with a $6,000,000 contract as the grand prize. The winning designs are available the next day in stores, using the Lilitab iPad kiosk at select Macy's.
Supermodel Elle Macpherson hosts the program with a panel of fashion mentors: Jessica Simpson, Nicole Richie and John Varvatos. Viewers get instant gratification, and the hottest new styles, by being able to purchase their ...
Two Massachusetts General Hospital (MGH)-based research teams, along with a group from the University of California at San Diego, have discovered that animals have a previously unknown system for detecting and responding to pathogens and toxins. In three papers published in the journals Cell and Cell Host & Microbe, the investigators describe finding evidence that disruptions to the core functions of animal cells trigger immune and detoxification responses, along with behavioral changes.
"Viewing many diseases through the prism of this newly discovered system will eventually ...
Chapel Hill, NC – In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases "en masse", enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies.
Kinases are proteins expressed in human tissues that play a key role in cell growth, particularly in cancer. Of the 518 known human kinases, about 400 are expressed in cancers, but which ones and how many are actually active in tumors has ...
There is a connection between phthalates found in cosmetics and plastics and the risk of developing diabetes among seniors. Even at a modest increase in circulating phthalate levels, the risk of diabetes is doubled. This conclusion is drawn by researchers at Uppsala University in a study published in the journal Diabetes Care.
"Although our results need to be confirmed in more studies, they do support the hypothesis that certain environmental chemicals can contribute to the development of diabetes," says Monica Lind, associate professor of environmental medicine at the ...
Meat consumption in the developed world needs to be cut by 50 per cent per person by 2050 if we are to meet the most aggressive strategy, set out by the Intergovernmental Panel on Climate Change (IPCC), to reduce one of the most important greenhouse gases, nitrous oxide (N2O).
This is the finding from a new study, published today, 13 April, in IOP Publishing's Environmental Research Letters, which also claims that N2O emissions from the industrial and agricultural sectors will also need to be cut by 50 per cent if targets are to be met.
The findings have been made ...
A team of researchers at Case Western Reserve University School of Medicine have identified a new mechanism by which colon cancer develops. By focusing on segments of DNA located between genes, or so-called "junk DNA," the team has discovered a set of master switches, i.e., gene enhancer elements, that turn "on and off" key genes whose altered expression is defining for colon cancers. They have coined the term Variant Enhancer Loci or "VELs," to describe these master switches.
Importantly, VELs are not mutations in the actual DNA sequence, but rather are changes in proteins ...
Inadequate knowledge about the effects of deepwater oil well blowouts such as the Deepwater Horizon event of 2010 threatens scientists' ability to help manage and assess comparable events in future, according to an article that a multi-author group of specialists will publish in the May issue of BioScience. Even federal "rapid response" grants awarded to study the Deepwater Horizon event were far more focused on near-surface effects than on the deepwater processes that the BioScience authors judge to be most in need of more research.
The article, by a team led by Charles ...
